Perioperative renal protection

Problems in Anesthesia

Volumn 9, Issue 3, 1997, Pages 314-331

  Sladen, Robert N ^a   Prough, Donald S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001504219     PISSN: 08894698     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Cullen DJ, Coyle JP, Teplick R, Long MC. Cardiovascular, pulmonary and renal effects of massively increased intra-abdominal pressure in critically ill patients. Crit Care Med 1989;17:118-121.
2. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA 1992;267:2344-2348.
3. Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Engl J Med 1986;314:97-105.
4. Brezis M, Rosen S, Epstein F. The pathophysiologic implications of medullary hypoxia. Am J Kidney Dis 1989;13:253-258.
5. Gelman S. Preserving renal function during surgery. Anesth Analg 1992;74:88-92.
6. Haywood GA, Tighe D, Moss R, et al. Goal directed therapy with dobutamine in a porcine model of septic shock: effects on systemic and renal oxygen transport. Postgrad Med J 1991;67(suppl 1):36-39.
7. Weber A, Schwieger IM, Poinsot O, Klohn M, Gaumann DM, Morel DR. Sequential changes in renal oxygen consumption and sodium transport during hyperdynamic sepsis in sheep. Am J Physiol 1992;262:F965-F971.
8. Myers B. Pathogenesis of postischemic acute renal failure in man. Kidney Int 1983;16:37-41.
9. Svensson LG, Coselli JS, Safi HJ, Hess KR, Crawford ES. Appraisal of adjuncts to prevent acute renal failure after surgery on the thoracic or thoracoabdominal aorta. J Vasc Surg 1989;10:230-239.
10. Hilberman M, Myers BD, Carrie BJ, Derby G, Jamison RL, Stinson EB. Acute renal failure following cardiac surgery. J Thorac Cardiovasc Surg 1979;77:880-888.
11. Moran S, Myers B. Pathophysiology of protracted acute renal failure in man. J Clin Invest 1985;76:1440-1448.
12. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997;95: 878-884.
13. Myers BD, Miller DC, Mehigan JT, et al. Nature of the renal injury following total renal ischemia in man. J Clin Invest 1984;73:329-341.
14. Pass LJ, Eberhart RC, Brown JC, Rohn GN, Estrera AS. The effect of mannitol and dopamine on the renal response to thoracic aortic cross-clamping. J Thorac Cardiovasc Surg 1988;95:608-612.
15. Gamulin Z, Forster A, Morel D, Simonet F, Aymon E, Favre H. Effects of infrarenal aortic cross-clamping on renal hemodynamics in humans. Anesthesiology 1984; 61:394-399.
16. Plusa SM, Clark NW. Prevention of postoperative renal dysfunction in patients with obstructive jaundice: a comparison of mannitol-induced diuresis and oral sodium taurocholate. J R Coll Surg Edinb 1991;36:303-305.
17. Morris JA Jr, Mucha P Jr, Ross SE, et al. Acute posttraumatic renal failure: a multicenter perspective. J Trauma 1991;31:1584-1590.
18. Harman PK, Kron IL, McLachlan HP, Freedlender AE, Nolan SP. Elevated intra-abdominal pressure and renal function. Ann Surg 1982;196:594-597.
19. Kron IL, Harman PK, Nolan SP. The measurement of intra-abdominal pressure as a criterion for abdominal reexploration. Ann Surg 1984;199:28-30.
20. Feinfeld DA, Cheng JT, Beysolow TD, Briscoe AM. A prospective study of urine and serum myoglobin levels in patients with acute rhabdomyolysis. Clin Nephrol 1992;38:193-195.
21. Wu AH, Laios I, Green S, et al. Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure. Clin Chem 1994;40: 796-802.
22. Ellinas PA, Rosner F. Rhabdomyolysis: report of eleven cases. J Natl Med Assoc 1992;84:617-624.
23. Bryan AG, Bolsin SN, Vianna PTG, Haloush H. Modification of the diuretic and natriuretic effects of a dopamine infusion by fluid loading in preoperative cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9:158-163.
24. Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 1985;27:928-937.
25. Shin B, Mackenzie CF, Helrich M. Creatinine clearance for early detection of posttraumatic renal dysfunction. Anesthesiology 1986;64:605-609.
26. Sladen RN, Endo E, Harrison T. Two-hour versus 22-hour creatinine clearance in critically ill patients. Anesthesiology 1987;67:1013-1016.
27. Memoli B, Libella C, Conte G, Andreucci VE. Loop diuretics and renal vasodilators in acute renal failure. Nephrol Dial Transplant 1994;9(suppl):168-171.
28. Krasna MJ, Scott GE, Scholz PM, Spotnitz AJ, Mackenzie JW, Penn F. Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy. Chest 1986;89:294-295.
29. Anderson RJ, Linas SL, Berns AS, et al. Nonoliguric acute renal failure. N Engl J Med 1977;296:1134-1137.
30. Brown C, Ogg C, Cameron J. High dose furosemide in acute renal failure: a controlled trial. Clin Nephrol 1981; 15:90-96.
31. Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med 1985;313:1330-1340.
32. Mason J. The pathophysiology of ischaemic acute renal failure: a new hypothesis about the initiation phase. Renal Physiol 1986;9:129-147.
33. Johnston PA, Bernard DB, Perrin NS, Levinsky NG. Prostaglandins mediate the vasodilatory effect of mannitol in the hypoperfused rat kidney. J Clin Invest 1981; 68:127-133.
34. Ip-Yam PC, Murphy S, Baines M, Fox MA, Desmond MJ, Innes PA. Renal function and proteinuria after cardiopulmonary bypass: the effects of temperature and mannitol. Anesth Analg 1994;78:842-847.
35. Bailey ME. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg 1976;630:774-778.
36. Wait RB, Kahng KU. Renal failure complicating obstructive jaundice. Am J Surg 1989;157:256-263.
37. Goldberg LI, Rajfer SI. Dopamine receptors: applications in clinical cardiology. Circulation 1985;72: 245-248.
38. Bello-Reuss E, Higashi Y, Kaneda Y. Dopamine decreases fluid reabsorption in straight portions of rabbit proximal tubule. Am J Physiol 1982;242:F634-F640.
39. Lokhandwala MF, Amenta F. Anatomical distribution and function of dopamine receptors in the kidney. FASEB J 1991;5:3023-3030.
40. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Am J Med 1996;101:49-53.
41. Richer M, Robert S, Lebel M. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 1996;24:1150-1156.
42. Costa P, Ottino GM, Matani A, et al. Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardiothorac Anesth 1990;4: 469-473.
43. Hilberman M, Maseda J, Stinson EB, et al. The diuretic properties of dopamine in patients after open-heart operation. Anesthesiology 1984;61:489-494.
44. Duke GJ, Briedis JH, Weaver RA. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit Care Med 1994;22:1919-1925.
45. Salem MG, Crooke JW, McLoughlin GA, Middle JG, Taylor WH. The effect of dopamine on renal function during aortic cross-clamping. Ann R Coll Surg Engl 1988;70:9-12.
46. Paul MD, Mazer CD, Byrick RJ, Rose DK, Goldstein MB. Influence of mannitol and dopamine on renal function during elective infrarenal aortic cross-clamping in man. Am J Nephrol 1986;6:427-434.
47. Baldwin L, Henderson A, Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 1994;120: 744-747.
48. Polson RJ, Park GR, Lindop MJ, Farman JV, Calne RY, Williams R. The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine. Anaesthesia 1987;42:15-19.
49. Swygert TH, Roberts LC, Valek TR, et al. Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology 1991;75:571-576.
50. De Los Angeles A, Baquero A, Bannett A, Raja R. Dopamine (D) Furosemide (F) infusion for prevention of posttransplant oliguric renal failure (TORF) (abstract). Kidney Int 1985;27:339.
51. Schwartz LB, Gewertz BL. The renal response to low dose dopamine. J Surg Res 1988;45:574-588.
52. Flancbaum L, Choban PS, Dasta JF. Quantitative effects of low-dose dopamine in urine output in oliguric surgical intensive care unit patients. Crit Care Med 1994;22:61-66.
53. ter Wee PM, Smit AJ, Rosman JB, Sluiter WJ, Donker AJ. Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 1986;6:42-46.
54. Smit AJ. Dopamine in chronic renal failure. Am J Hypertens 1990;3:75S-77S.
55. Chiolero R, Borgeat A, Fisher A. Postoperative arrhythmias and risk factors after open heart surgery. Thorac Cardiovasc Surg 1991;39:81-84.
56. Ghosh S, Gray B, Oduro A, Latimer RD. Dopexamine hydrochloride: pharmacology and use in low cardiac output states. J Cardiothorac Vasc Anesth 1991;5:382-389.
57. Bums A, Gray PA, Bodenham AR, Park GR. Dopexamine: studies in the general intensive care unit and after liver transplantation. J Auton Pharmacol 1990;10(suppl 1):S109-S114.
58. de Fijter CW, Comans EF, de Vries PM, et al. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure. Neth J Med 1990;36:267-278.
59. Neumayer HH, Gellert J, Luft FC. Calcium antagonists and renal protection. Ren Fail 1993;15:353-358.
60. Diamond J, Cheung J, Fang L. Nifedipine-induced renal dysfunction. Am J Med 1984;77:905-909.
61. Bauer JH, Sunderrajan S, Reams G. Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition. Am J Cardiol 1985;56:62H-67H.
62. Neumayer HH, Kunzendorf U, Schrieber M. Protective effects of calcium antagonists in human renal transplantation. Kidney Int 1992;36:87-93.
63. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrol Dial Transplant 1989;4:1030-1036.
64. Bender W, La France N, Walker WG. Mechanism of deterioration in renal function in patients with renovascular hypertension treated with enalapril. Hypertension 1984;6:I193-I197.
65. Colson P, Ribstein J, Mimran A, Grolleau D, Chaptal PA, Roquefeuil B. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology 1990;72:23-27.
66. Shaw S, Weidmann P, Zimmermann A. Urodilatin, not nitroprusside, combined with dopamine reverses ischemic acute renal failure. Kidney Int 1992;42: 1153-1159.
67. Levenson DJ, Simmons CE, Brenner BM. Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med 1982;72:354-374.
68. Clive D, Stoff J. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984;310:563-572.
69. Feldman HI, Kinman JL, Berlin JA, et al. Parenteral ketorolac: the risk for acute renal failure. Ann Intern Med 1997;126:193-199.
70. Stanton BA, Koeppen BM. Control of body fluid osmolality and volume. In: Berne RM, Levy MN, eds. Physiology. St. Louis: Mosby Year Book; 1993:754-783.
71. Shannon RP, Libby E, Elahi D, et al. Impact of acute reduction in chronically elevated left atrial pressure on sodium and water excretion. Ann Thorac Surg 1988;46:430-437.
72. Alkhunaizi AM, Schrier RW. Management of acute renal failure: new perspectives. Am J Kidney Dis 1996;28: 315-328.
73. Conger JD. Interventions in clinical acute renal failure: what are the data? Am J Kidney Dis 1995;26:565-576.
74. Atanasova I, Girchev R, Dimitrov D, et al. Atrial natriuretic peptide and dopamine in a dog model of acute renal ischemia. Acta Physiol Hung 1994;82:75-85.
75. Seki G, Suzuki K, Nonaka T, et al. Effects of atrial natriuretic peptide on glycerol induced acute renal failure in the rat. Jpn Heart J 1992;33:383-393.
76. Conger JD, Falk SA, Hammond WS. Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 1991;40:21-28.
77. Cedidi C, Meyer M, Kuse ER, et al. Urodilatin: a new approach for the treatment of therapy-resistant acute renal failure after liver transplantation. Eur J Clin Invest 1994;24:632-639.
78. Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis. N Engl J Med 1997;336:828-834.